Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bangun Kosambi Sukses Tbk. (CBDK) vs Merck Tbk. (MERK) Price & Performance

Bangun Kosambi Sukses Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Bangun Kosambi Sukses Tbk. vs Merck Tbk. — how do they compare? Bangun Kosambi Sukses Tbk. trades at Rp3,530 (market cap 19.84T, 690K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 26.9K 24h volume). The key difference: Bangun Kosambi Sukses Tbk. is far larger — about 11.7× Merck Tbk.'s market cap, and Bangun Kosambi Sukses Tbk. is more actively traded (690K versus 26.9K). Which is the better fit depends on your goals.

CBDKMERK
Market Cap
19.84T1.7T
Volume
690K26.9K
Lot
6.9K269
Turnover
2.42B103.24M
Average Price
3,510.083,837.73
Value
2.42B103.24M
Indicative Equilibrium Price
3,5503,850
Indicative Equilibrium Volume
71

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CBDK
View details
MERK
View details

About Bangun Kosambi Sukses Tbk.

PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.

Read more on CBDK

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK